Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Skeletal Radiology

01-10-2005 | Review Article

Heterotopic ossification: a review

Published in: Skeletal Radiology | Issue 10/2005

Login to get access

Abstract

Heterotopic ossification is the formation of bone in the soft tissues. Soft tissue bone deposition may range from the minimal and inconsequential to massive and clinically significant. In some clinical settings it is a predictable finding with an unpredictable course and in other settings it may be diagnostically confounding. Heterotopic ossification may be encountered in clinically disparate disease processes and circumstances. We review the genetic, neurogenic, post-traumatic, post-surgical and “reactive” causes of heterotopic ossification and discuss some current concepts of its pathogenesis.

Literature
  1. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993; 91:1800–1809.PubMed
  2. Wilson JD, Montague CJ, Salcuni P, Bordi C, Rosai J. Heterotopic mesenteric ossification (“intraabdominal myositis ossificans”): report of five cases. Am J Surg Pathol 1999; 23:1464–1470.View ArticlePubMed
  3. Kaplan FS, Glaser DL, Hebela N, Shore EM. Heterotopic ossification. J Am Acad Orthop Surg 2004; 12:116–125.PubMed
  4. Urist MR. Bone: formation by autoinduction. 1965. Clin Orthop 2002;395:4–10.PubMed
  5. Kaplan FS. Skin and bones. Arch Dermatol 1996; 132:815–818.View ArticlePubMed
  6. Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994; 8:133–146.PubMed
  7. Wozney JM, Rosen V, Byrne M, Celeste AJ, Moutsatsos I, Wang EA. Growth factors influencing bone development. J Cell Sci Suppl 1990; 13:149–56.PubMed
  8. Jones CM, Lyons KM, Hogan BL. Involvement of Bone Morphogenetic Protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. Development 1991; 111:531–542.PubMed
  9. Nakase T, Nomura S, Yoshikawa H, Hashimoto J, Hirota S, Kitamura Y, et al. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res 1994; 9:651–659.PubMed
  10. Shore EM, Glaser DL, Gannon FH. Osteogenic induction in hereditary disorders of heterotopic ossification. Clin Orthop 2000; 374:303–316.View ArticlePubMed
  11. DeWitt LM. Myositis ossificans with a report of two cases. Am J Med Sci 1900; 120:295–309.
  12. Munchmeyer. Ueber myositis ossificans progressiva. Zeitschr Rationelle Med 1869; 34:9.
  13. Cohen RB, Hahn GV, Tabas JA, Peeper J, Levitz CL, Sando A, et al. The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients. J Bone Joint Surg Am 1993; 75:215–219.PubMed
  14. Campbell RK. Myositis ossificans progressiva. Radiol Rev 1933; 55:153.
  15. Smith R, Russell RG, Woods CG. Myositis ossificans progressiva. Clinical features of eight patients and their response to treatment. J Bone Joint Surg Br 1976; 58:48–57.PubMed
  16. Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub R, Muenke M, et al. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 1996; 335:555–561.View ArticlePubMed
  17. Feldman G, Li M, Martin S, Urbanek M, Urtizberea JA, Fardeau M, et al. Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27–31. Am J Hum Genet 2000; 661:128–135.View Article
  18. Semonin O, Fontaine K, Daviaud C, Ayuso C, Lucotte G. Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva. Am J Med Genet 2001; 102:314–317.View ArticlePubMed
  19. Gazzerro E, Gangji V, Canalis E. Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts . J Clin Invest 1998; 102:2106–2114.PubMed
  20. Ahn J, Serrano DLP, Shore EM, Kaplan FS. Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis. J Bone Joint Surg Am 2003; 85:667–674.PubMed
  21. Gannon FH, Kaplan FS, Olmsted E, Finkel GC, Zasloff MA, Shore E. Bone morphogenetic protein 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva. Hum Pathol 1997; 28:339–343.View ArticlePubMed
  22. Kaplan FS, Tabas JA, Gannon FH, Finkel G, Hahn GV, Zasloff MA. The histopathology of fibrodysplasia ossificans progressiva. An endochondral process. J Bone Joint Surg Am 1993; 75:220–230.PubMed
  23. Kaplan FS, Craver R, MacEwen GD, Gannon FH, Finkel G, Hahn G, et al. Progressive osseous heteroplasia: a distinct developmental disorder of heterotopic ossification. Two new case reports and follow-up of three previously reported cases. J Bone Joint Surg Am 1994; 76:425–436.PubMed
  24. Kaplan FS, Shore EM. Progressive osseous heteroplasia. J Bone Miner Res 2000; 15:2084–2094.PubMed
  25. Eddy MC, De Beur SM, Yandow SM, McAlister WH, Shore EM, Kaplan FS, et al. Deficiency of the alpha-subunit of the stimulatory G protein and severe extraskeletal ossification. J Bone Miner Res 2000; 15:2074–2083.PubMed
  26. Weinstein LS, Chen M, Liu J. Gs(alpha) mutations and imprinting defects in human disease. Ann N Y Acad Sci 2002; 968:173–197.PubMed
  27. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991; 325:1688–1695.PubMed
  28. Heifetz SA, Galliani CA, DeRosa GP. Myositis (fasciitis) ossificans in an infant. Pediatr Pathol 1992; 12:223–229.PubMed
  29. DeSmet AA, Norris MA, Fisher DR. Magnetic resonance imaging of myositis ossificans: analysis of seven cases. Skeletal Radiol 1992; 21:503–507.PubMed
  30. Cvitanic O, Sedlak J. Acute myositis ossificans. Skeletal Radiol 1995; 24:139–141.View ArticlePubMed
  31. Ehara S, Shiraishi H, Abe M, Mizutani H. Reactive heterotopic ossification ITS patterns on MRI. Clin Imaging 1998; 22:292–296.View ArticlePubMed
  32. Ogilvie-Harris DJ, Fornasier VL. Pseudomalignant myositis ossificans: heterotopic new-bone formation without a history of trauma. J Bone Joint Surg Am 1980; 62:1274–1283.PubMed
  33. Lagier R, Cox JN. Pseudomalignant myositis ossificans. A pathological study of eight cases. Hum Pathol 1975; 6:653–665.PubMed
  34. Kaplan FS, Gannon FH, Hahn GV, Wollner N, Prauner R. Pseudomalignant heterotopic ossification. Differential diagnosis and report of two cases. Clin Orthop 1998; 346:134–140.PubMed
  35. Mody BS, Patil SS, Carty H, Klenerman L. Fracture through the bone of traumatic myositis ossificans. A report of three cases. J Bone Joint Surg Br 1994; 76:607–609.PubMed
  36. Amir G, Mogle P, Sucher E. Case report 729. Myositis ossificans and aneurysmal bone cyst. Skeletal Radiol 1992; 21:257–259.View ArticlePubMed
  37. Konishi E, Kusuzaki K, Murata H, Tsuchihashi Y, Beabout JW, Unni KK. Extraskeletal osteosarcoma arising in myositis ossificans. Skeletal Radiol 2001; 30:39–43.View ArticlePubMed
  38. Damanski M. Heterotopic ossification in paraplegia. J Bone Joint Surg Br 1961; 43:286–299.
  39. Botte MJ, Keenan MAE, Abrams RA, von Schroeder HP, Gellman H, Mooney V. Heterotopic ossification in neuromuscular disorders. Orthopedics 1997; 20:335–341.PubMed
  40. Garland DE. A clinical perspective on common forms of acquired heterotopic ossification. Clin Orthop 1991; 263:13–29.PubMed
  41. Goodman TA, Merkel PA, Perlmutter G, Doyle MK, Krane SM, Polisson RP. Heterotopic ossification in the setting of neuromuscular blockade. Arthritis Rheum 1997; 40:1619–1627.PubMed
  42. Taly AB, Nair KP, Kumar MV, Jayakumar PN, Vasudev MK, Ravishankar D, et al. Heterotopic ossification in non-traumatic myelopathies. Spinal Cord 1999; 37:47–49.View ArticlePubMed
  43. Milgram J. (1990) Myositis ossificans and heterotopic bone. In: Gruhn J, ed. Radiologic and histologic pathology of nontumorous diseases of bones and joints. Illinois: Northbrook Publishing, 1990:454.
  44. Riegler HF, Harris CM. Heterotopic bone formation after total hip arthroplasty. Clin Orthop 1976; 117:209–216.PubMed
  45. Thomas BJ. Heterotopic bone formation after total hip arthroplasty. Orthop Clin North Am 1992; 23:347–358.PubMed
  46. Brooker AF, Bowerman JW, Robinson RA, Riley LH, Jr. Ectopic ossification following total hip replacement. Incidence and method of classification. J Bone Joint Surg Am 1973; 55:1629–1632.PubMed
  47. Kjaersgaard-Andersen P, Ritter MA. Prevention of formation of heterotopic bone after total hip arthroplasty. J Bone Joint Surg Am 1991; 73:942–947.PubMed
  48. Nilsson OS, Persson PE. Heterotopic bone formation after joint replacement. Curr Opin Rheumatol 1999; 11:127–131.View ArticlePubMed
  49. Nuovo MA, Norman A, Chumas J, Ackerman LV. Myositis ossificans with atypical clinical, radiographic, or pathologic findings: a review of 23 cases. Skeletal Radiol 1992; 21:87–101.View ArticlePubMed
  50. Johnson MK, Lawrence JF. Metaplastic bone formation (myositis ossificans) in the soft tissues of the hand. J Bone Joint Surg AM 1975; 57:999–1000.PubMed
  51. Yuen M, Friedman L, Orr W, Cockshott WP. Proliferative periosteal processes of phalanges: a unitary hypothesis. Skeletal Radiol 1992; 21:301–303.View ArticlePubMed
  52. Sundaram M, Wang L, Rotman M, Howard R, Saboeiro AP. Florid reactive periostitis and bizarre parosteal osteochondromatous proliferation: pre-biopsy imaging evolution, treatment and outcome. Skeletal Radiol 2001; 30:192–198.View ArticlePubMed
  53. Wissinger HA, McClain EJ, Boyes JH. Turret exostosis. Ossifying hematoma of the phalanges. J Bone Joint Surg Am 1966; 48:105–110.PubMed
  54. Abramovici L, Steiner GC. Bizarre parosteal osteochondromatous proliferation (Nora’s lesion): a retrospective study of 12 cases, 2 arising in long bones. Hum Pathol 2002; 33:1205–1210.View ArticlePubMed
  55. Meneses MF, Unni KK, Swee RG. Bizarre parosteal osteochondromatous proliferation of bone (Nora’s lesion). Am J Surg Pathol 1993; 17:691–697.PubMed
  56. Helliwell TR, O’Connor MA, Ritchie DA, Feldberg L, Stilwell JH, Jane MJ. Bizarre parosteal osteochondromatous proliferation with cortical invasion. Skeletal Radiol 2001; 30:282–285.View ArticlePubMed
  57. Nora FE, Dahlin D, Beabout JW. Bizarre parosteal osteochondromatous proliferations of the hands and feet. Am J Surg Pathol 1983; 7:245–250.PubMed
  58. Spjut HJ, Dorfman HD. Florid reactive periostitis of the tubular bones of the hands and feet. A benign lesion which may simulate osteosarcoma. Am J Surg Pathol 1981; 5:423–433.PubMed
  59. Landon GC, Johnson KA, Dahlin DC. Subungual exostoses. J Bone Joint Surg Am 1979; 61:256–259.PubMed
  60. Zambrano E, Nose V, Perez-Atayde AR, et al. Distinct chromosomal rearrangements in subunqual (Dupuytren’s) exostosis and bizarre parosteal osteochondromatous proliferation (Nora lesion), Am J Surg Pathol 2004, 8:1033–1039.
Metadata
Title
Heterotopic ossification: a review
Publication date
01-10-2005
Published in
Skeletal Radiology / Issue 10/2005
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-005-0958-z